| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |